Other Events ·
At its annual meeting on June 10, 2026, Milestone Pharmaceuticals Inc. shareholders approved an amendment to the 2019…
MISTMilestone Pharmaceuticals Inc.
At its annual meeting on June 10, 2026, Milestone Pharmaceuticals Inc. shareholders approved an amendment to the 2019 Equity Incentive Plan, increasing authorized ordinary shares for issuance by 6,800,000. Shareholders also elected seven directors, including Joseph Oliveto, Stuart M. Duty, Seth H.Z. Fischer, Lisa M. Giles, Joseph C. Papa, Andrew R. Saik, and Michael Tomsicek, to serve until the 2027 annual meeting. Additionally, the meeting resulted in the ratification of PricewaterhouseCoopers LLP as the company's auditor and a non-binding advisory vote on executive compensation. Milestone Pharmaceuticals Inc. is a pharmaceutical company.